Cargando…
Myostatin: a potential therapeutic target for metabolic syndrome
Metabolic syndrome is a complex metabolic disorder, its main clinical manifestations are obesity, hyperglycemia, hypertension and hyperlipidemia. Although metabolic syndrome has been the focus of research in recent decades, it has been proposed that the occurrence and development of metabolic syndro...
Autores principales: | Yang, Ming, Liu, Chongbin, Jiang, Na, Liu, Yan, Luo, Shilu, Li, Chenrui, Zhao, Hao, Han, Yachun, Chen, Wei, Li, Li, Xiao, Li, Sun, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242177/ https://www.ncbi.nlm.nih.gov/pubmed/37288303 http://dx.doi.org/10.3389/fendo.2023.1181913 |
Ejemplares similares
-
Fibroblast growth factor 21 in metabolic syndrome
por: Yang, Ming, et al.
Publicado: (2023) -
Endoplasmic reticulum homeostasis: a potential target for diabetic nephropathy
por: Yang, Ming, et al.
Publicado: (2023) -
Mitochondrial homeostasis: a potential target for delaying renal aging
por: Yang, Ming, et al.
Publicado: (2023) -
Caveolin-1 Regulates Cellular Metabolism: A Potential Therapeutic Target in Kidney Disease
por: Luo, Shilu, et al.
Publicado: (2021) -
MAMs Protect Against Ectopic Fat Deposition and Lipid-Related Kidney Damage in DN Patients
por: Yang, Ming, et al.
Publicado: (2021)